FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and the pharmaceutical industry, namely to surgery, dermatology, obstetrics and gynecology, otorhinolaryngology, and is intended for the treatment of pyoinflammatory processes of soft tissues and mucous membranes. An agent for the treatment of purulent-inflammatory processes of soft tissues and mucous membranes is an ointment and contains a combination of the antiseptic hexetidine and the photosensitizer photoditazine as therapeutic components, and methylcellulose as the basis. Components are used in the declared quantities.
EFFECT: use of the invention provides an effective antimicrobial, sorption and wound healing effect.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES OF SOFT TISSUES AND MUCOUS MEMBRANES | 2010 |
|
RU2445083C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2605343C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2603490C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2013 |
|
RU2542376C1 |
AGENT FOR TREATING PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2015 |
|
RU2601897C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2013 |
|
RU2542373C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2641095C1 |
WOUND HEALING PRODUCT IN THE FORM OF AN OINTMENT CONTAINING RUBIDIUM CHLORIDE | 2019 |
|
RU2722127C1 |
HYDROGEL COMPOSITION FOR TREATING INVESTING TISSUE DEFECTS BY PHOTODYNAMIC THERAPY | 2020 |
|
RU2730850C1 |
Authors
Dates
2022-06-21—Published
2021-11-25—Filed